ProMIS Neurosciences, Inc. (PMN) Financials

PMN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 67.4 million 6.7 million
Dec. 31, 2025 9.2 million 10.4 million
Sept. 30, 2025 21.5 million 12.3 million
June 30, 2025 9.5 million 9.9 million

PMN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.4 million ?
Dec. 31, 2025 -9.1 million 857.0 million
Sept. 30, 2025 -10.2 million 197147
June 30, 2025 -3.9 million 212015

PMN Net Income

No data available :(

PMN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 63.8 million - -
Dec. 31, 2025 6.2 million - -
Sept. 30, 2025 15.4 million - -
June 30, 2025 4.5 million - -

PMN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 6.5 million
Dec. 31, 2025 1.8 million
Sept. 30, 2025 1.4 million
June 30, 2025 1.4 million

PMN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 7.0 million 1.7 million -
Dec. 31, 2025 - 9.4 million 1.4 million -
Sept. 30, 2025 2 9.8 million 2.0 million -
June 30, 2025 - 8.7 million 1.4 million -

PMN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

PMN

Price: $12.34

52 week price:
6.27
39.75

Earnings Per Share: -18.60 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 17.5 million

Links: